Staphylococcal toxic shock syndrome

Common Name(s)

Staphylococcal toxic shock syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Staphylococcal toxic shock syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Staphylococcal toxic shock syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Staphylococcal toxic shock syndrome" returned 39 free, full-text research articles on human participants. First 3 results:

[Staphylococcal toxic shock syndrome after breast surgery].
 

Author(s): A Pelissier, J Dumesnil, R Levy, C Charron, R Rouzier

Journal: J Gynecol Obstet Biol Reprod (Paris). 2014 Sep;43(7):526-9.

 

The surgical site infection occurs within 30 days after surgery. It is the most common complication of surgery, with a rate of 1 to 5% without antibiotic prophylaxis and less than 1% with antibiotic prophylaxis. The toxic shock syndrome (TSS) is a dramatic complication. We report ...

Last Updated: 6 Aug 2014

Go To URL
Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome.
 

Author(s): Hani Kim, Ilyse Darwish, Maria-Fernanda Monroy, Darwin J Prockop, W Conrad Liles, Kevin C Kain

Journal:

 

Toxic shock syndrome (TSS) is caused by an overwhelming host-mediated response to bacterial superantigens produced mainly by Staphylococcus aureus and Streptococcus pyogenes. TSS is characterized by aberrant activation of T cells and excessive release of pro-inflammatory cytokines ...

Last Updated: 20 Jan 2014

Go To URL
Images in clinical medicine. Staphylococcal toxic shock syndrome.
 

Author(s): Bob C Y Chan, Paul Maurice

Journal: N. Engl. J. Med.. 2013 Aug;369(9):852.

 

Last Updated: 29 Aug 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Staphylococcal toxic shock syndrome" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study
 

Status: Recruiting

Condition Summary: Toxic Shock Syndrome

 

Last Updated: 15 Mar 2016

Go to URL
Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children
 

Status: Not yet recruiting

Condition Summary: Staphylococcal Infection; Streptococcal Infection

 

Last Updated: 8 Sep 2016

Go to URL